Kara Anoskey, NP
Primary Care · Westfield, INNPI 1235732256
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations.
Across 24 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$73
- Amgen$64
- E.r. Squibb & Sons, L.L.C.$43
- Morphosys, US Inc.$35
- Lilly USA, LLC$34
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$24
- plus $211 from 12 others
What the payments were for
- Food & beverage$484100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 1 | $73 |
| Amgen | 4 | $64 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Morphosys, US Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Novartis | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| GSK | 1 | $20 |
| AbbVie | 1 | $20 |
| Dova Pharmaceuticals | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Pfizer | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$484 in reported general payments places this provider in the 60th percentile of 113 primary care providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 47 | $500 |
| Lisinopril | 43 | $462 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $424 |
| Amlodipine Besylate | 50 | $333 |
| Metoprolol Succinate | 32 | $247 |
| Levothyroxine Sodium | 18 | $203 |
| Rosuvastatin Calcium | 16 | $178 |
| Omeprazole | 28 | $137 |
| Escitalopram Oxalate | 14 | $131 |
| Alendronate Sodium | 11 | $129 |
| Hydrochlorothiazide | 19 | $123 |
| Metformin Hcl ErMetformin Hcl | 28 | $74 |
| Losartan Potassium | 12 | $58 |
| Cyclobenzaprine Hcl | 23 | $54 |
| Meloxicam | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other primary care in Westfield
- Katrina MotleyIndianapolis$18K
- Stephanie BodamerBloomington$6K
- Candace KapranosGary$5K
- Jalyn GoolsbyNew Albany$4K
- Ashley VirtMuncie$4K
- Lana HumeCarmel$3K
- Illia LeiberingTell City$3K
- Jiyoung ChaeWest Lafayette$3K
- Leigha Bowyer-JonesJeffersonville$3K
- Heather PickettNoblesville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.